Critical Analysis: Kindly MD (NASDAQ:KDLY) & GeneDx (NASDAQ:WGS)

Kindly MD (NASDAQ:KDLY) and GeneDx (NASDAQ:WGS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations.

Profitability

This table compares Kindly MD and GeneDx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kindly MD	N/A	N/A	N/A
GeneDx	-31.25%	-13.35%	-6.91%

Valuation and Earnings

This table compares Kindly MD and GeneDx”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kindly MD	N/A	N/A	N/A	N/A	N/A
GeneDx	$202.57 million	10.10	-$175.77 million	($3.11)	-24.42

Kindly MD has higher earnings, but lower revenue than GeneDx.

Institutional & Insider Ownership

61.7% of GeneDx shares are owned by institutional investors. 50.5% of Kindly MD shares are owned by company insiders. Comparatively, 27.3% of GeneDx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Kindly MD and GeneDx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kindly MD	0	0	0	0	0.00
GeneDx	0	3	3	0	2.50

GeneDx has a consensus target price of $59.33, indicating a potential downside of 21.88%. Given GeneDx’s stronger consensus rating and higher probable upside, analysts clearly believe GeneDx is more favorable than Kindly MD.

Summary

GeneDx beats Kindly MD on 5 of the 9 factors compared between the two stocks.

About Kindly MD

KindlyMD Inc. is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme. KindlyMD Inc. is based in SALT LAKE CITY, UT.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.